buy sell hold 2021

UOB KAYHIAN CGS CIMB
Aoxin Q & M Dental Group (AOXIN SP)
Potential Unlocking Of Huge Value Via Nasdaq Listing Of Associated Company

Aoxin’s 49% associated company, Acumen, is exploring a listing on Nasdaq. Our basecase estimate using 22x 2021F PE for Acumen, based on Q&M Dental’s historical mean PE, will unlock value of S$216m (S$0.42/share) for Aoxin. Compared to current market cap of Aoxin at S$127m (S$0.25/share), shareholders will enjoy more than 70% upside in value accretion upon successful of listing, with continued ownership of the China dental business. Maintain BUY and target price of S$0.37 (16x 2022F PE).
Read More ...

Keppel Corporation
4Q21F: Generous dividend


■ We expect KEP to report c.53% hoh increase in net profit in 2H21F (on 27 Jan) to S$459m, boosted by divestment gains of c.S$396m.
■ KEP clocked in S$1.6bn of proceeds in 2H21F from asset recycling efforts, paving way for stronger final DPS of S$0.16-0.18 (FY21F: S$0.28-S$0.30)
■ Reiterate Add with higher SOP TP of S$7.20 as we roll over to FY23F.
■ KEP trades at 0.85x and 11x CY22F P/BV and P/E, -1 sd below its historical
average. Catalyst: aggressive asset recycling and earnings accretive M&As. 

 

Read More ...

MAYBANK KIM ENG

UOB KAYHIAN

Axis REIT (AXRB MK)
Higher acquisition targets


Maintain as top BUY

4QFY21 core earnings and 4th interim gross DPU of 2.41sen (FY21: 9.49sen) were within expectations, with FY21 earnings coming in at 96%/100% of our/consensus estimates. We adjust higher our FY22/23E earnings by 1%/12%, which increases our rolled-forward DDM-TP to MYR2.30. Maintain BUY. Axis remains as our top pick in the REITs sector, supported by resilient rental income from industrial properties and active assets acquisitions.

 

Read More ...

 

 

 

 

Sentral REIT (SENTRAL MK)
4Q21: Results Within Expectations


Sentral REIT’s results came in within our estimates, with full-year 2021 core earnings
accounting for 98% of our full-year forecast. Operations remain fairly resilient and we
believe SENTRAL will continue to report decent results moving forward, given that its
tenants are mostly well-established MNCs. The stock offers an attractive dividend yield
of at least 8% from 2022 onwards. Maintain BUY and target price of RM1.00. 

 

Read More ...


Share Prices

Counter NameLastChange
AEM Holdings4.280-0.030
Avi-Tech Electronics0.320-
Broadway Ind0.186-0.001
China Sunsine0.440-
DISA0.004-
Food Empire0.535-
Fortress Minerals0.420-0.025
Geo Energy Res0.440-
Golden Energy0.750-
GSS Energy0.060-
InnoTek0.540-0.005
ISDN Holdings0.545-0.005
ISOTeam0.1080.003
IX Biopharma0.172-0.002
Jiutian Chemical0.109-
KSH Holdings0.350-
Leader Env0.059-0.001
Medtecs Intl0.189-0.004
Meta Health0.038-0.001
Moya Asia0.055-
Nordic Group0.4050.010
Oxley Holdings0.1770.002
REX International0.2900.010
Riverstone0.7550.005
Sinostar PEC0.230-
Southern Alliance Mining0.620-0.005
Straco Corp.0.400-0.020
Sunpower Group0.4050.005
The Trendlines0.104-
Totm Technologies0.142-0.004
UG Healthcare0.225-
Uni-Asia Group1.060-0.070
Wilmar Intl4.100-
Yangzijiang Shipbldg0.900-0.005

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 2209 guests and no members online